Figure 1From: Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients Flow - chart: treatment and Foxp3 + Treg blood sample schedule. Back to article page